Alira Health Secures Up to $100M Growth Debt Facility from Symbiotic Capital to Propel Strategic Expansion and Patient-Enabled Innovation
17 déc. 2024 09h00 HE
|
Alira Health
Alira Health announced today the securing of up to $100 million in growth debt from Symbiotic Capital, a premier healthcare and life sciences investor.
Sobi Announces FDA Acceptance of New Drug Application for Avatrombopag (DOPTELET®) for the Treatment of Pediatric Immune Thrombocytopenia
12 déc. 2024 06h59 HE
|
Sobi, Inc.
WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced that the U.S. Food and Drug Administration...
Biopharma Leaders of Color (BLOC) Announces Board of Directors and Establishes Executive Council to Expand and Enhance Offerings
19 nov. 2024 09h00 HE
|
Biopharma Leaders of Color, Inc.
Biopharma Leaders of Color (BLOC) Announces Board of Directors and Establishes Executive Council to Expand and Enhance Offerings
2024 BioTech Breakthrough Awards Program Celebrates Groundbreaking Biotechnology Innovators Around the World
19 nov. 2024 08h00 HE
|
BioTech Breakthrough
LOS ANGELES, Nov. 19, 2024 (GLOBE NEWSWIRE) -- BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology...
EvolveImmune Therapeutics Presents New Preclinical and Translational Data Highlighting Pipeline Progress for EVOLVE T Cell Engager Platform at 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
11 nov. 2024 07h00 HE
|
EvolveImmune
Poster Presentations Spotlight Differentiated Therapeutic Profile and Precision Therapeutic Strategy for Lead Development Candidate EVOLVE104 as Program Advances Toward Clinic for Solid Tumors EVOLVE...
The Accumulus Platform Powers Sanofi’s Submissions to Multiple Regulators Around the World
07 nov. 2024 09h05 HE
|
Accumulus Synergy
BURLINGAME, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy, Inc. (“Accumulus”), is revolutionizing the scalability of reliance pathways, enabling a recent submission from Sanofi to...
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
04 nov. 2024 07h00 HE
|
Lifecore Biomedical, Inc.
Brings Strong Background in Pharmaceutical Manufacturing Operations and Finance to Help Drive Performance and Productivity Jackie Klecker Named Executive Vice President, Quality and Development...
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
01 nov. 2024 16h30 HE
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
Immunophotonics to Present at the 2024 ThinkEquity Conference
28 oct. 2024 08h30 HE
|
Immunophotonics, Inc.
Immunophotonics to Present at the 2024 ThinkEquity Conference
Cellectis to Present Data on TALE-Base Editors and Non-Viral Gene Therapy at the ESGCT 31st Annual Congress
22 oct. 2024 02h00 HE
|
Cellectis Inc.
NEW YORK, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...